儿童与年轻成人骨髓增殖性肿瘤的特征分析
本研究比较了630例骨髓增殖性肿瘤(MPN)患者中儿童与年轻成人(PAYA,<40岁)与老年成人(OA,≥40岁)的基因组特征和临床结局。PAYA占27%,诊断时平均年龄31岁,女性比例更高,更常见原发性血小板增多症,CALR突变或无传统驱动突变更常见,静脉血栓更常见,生存期更长且疾病转化更少。
要点
- PAYA组女性比例71% vs OA组58%(p=0.002),PAYA更常见ET(67% vs 39%,p<0.001)。
- PAYA组CALR突变20.5% vs OA组10.5%(p=0.001),无传统驱动突变8.8% vs 3.7%(p=0.01)。
- PAYA组静脉血栓19.8% vs OA组10.7%(p=0.002),疾病转化19.3% vs 37.9%。
核心结论
- PAYA与OA的MPN在基因组特征和临床结局上存在差异,PAYA生存期更长且疾病转化更少。
研究设计与样本
- 630例MPN患者的比较研究,其中171例(27%)为PAYA(<40岁),诊断时平均年龄31岁。
主要发现
- PAYA组女性比例71% vs OA组58%(p=0.002)。
- PAYA组诊断时ET比例67% vs OA组39%(p<0.001)。
- OA组JAK2体细胞突变80.4% vs PAYA组64.3%(p<0.001)。
- PAYA组CALR突变20.5% vs OA组10.5%(p=0.001),无传统驱动突变8.8% vs 3.7%(p=0.01)。
- PAYA组静脉血栓19.8% vs OA组10.7%(p=0.002),疾病转化19.3% vs 37.9%,PAYA生存期更长(中位未达到 vs 13年)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this study was to compare the genomic features and clinical outcomes between paediatric and young adult patients (PAYA, <40 years) and older adults (OA, ≥40 years) with myeloproliferative neoplasms (MPN) to gain insight into pathogenesis, disease prognosis and management. Of 630 MPN patients, 171 (27%) were PAYA with an average age at diagnosis of 31 years. Females were more prevalent in PAYA than OA (71% vs 58%; p = 0.002), and PAYA more frequently presented with essential thrombocytosis (ET) at diagnosis (67% vs 39%; p < 0.001). The presence of a JAK2 somatic mutation was higher in OA (80.4% vs 64.3%; p < 0.001), while a CALR mutation or lack of any traditional driver mutation was more common in PAYA (20.5% vs 10.5%; p = 0.001, 8.8% vs 3.7%; p = 0.01 respectively). Venous thrombosis was more common in PAYA compared to OA (19.8% vs 10.7%; p = 0.002). PAYA had a higher prevalence of familial MPN and familial cancer predisposition, and two PAYA patients harboured pathogenic germline JAK2 lesions. PAYA demonstrated longer survival from diagnosis than OA (median not reached vs 13 years), while disease transformation was less frequent (19.3% vs 37.9%).
引用
- Harris Z, Kaizer H, Wei A, et al. Characterization of myeloproliferative neoplasms in the paediatric and young adult population. Br J Haematol. 2023. PMID: 36647302. doi:10.1111/bjh.18650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。